481 related articles for article (PubMed ID: 34325714)
21. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
Wang M; Zhang Y; Xu Z; Qian P; Sun W; Wang X; Jian Z; Xia T; Xu Y; Tang J
Cell Commun Signal; 2020 Aug; 18(1):128. PubMed ID: 32807176
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE
Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852
[TBL] [Abstract][Full Text] [Related]
23. A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation.
Liang ZX; Liu HS; Xiong L; Yang X; Wang FW; Zeng ZW; He XW; Wu XR; Lan P
Mol Cancer; 2021 Aug; 20(1):103. PubMed ID: 34412652
[TBL] [Abstract][Full Text] [Related]
24. IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis.
Liang M; Ma Q; Ding N; Luo F; Bai Y; Kang F; Gong X; Dong R; Dai J; Dai Q; Dou C; Dong S
Cell Death Dis; 2019 Apr; 10(5):353. PubMed ID: 31040267
[TBL] [Abstract][Full Text] [Related]
25. CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis.
Wu J; Jiang Z; Chen C; Hu Q; Fu Z; Chen J; Wang Z; Wang Q; Li A; Marks JR; Guo C; Chen Y; Zhou J; Yang L; Lin C; Wang S
Cancer Lett; 2018 Aug; 430():179-192. PubMed ID: 29803789
[TBL] [Abstract][Full Text] [Related]
26. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH
J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829
[TBL] [Abstract][Full Text] [Related]
27. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop.
Zheng W; Wang X; Yu Y; Ji C; Fang L
Cell Mol Biol Lett; 2023 Apr; 28(1):34. PubMed ID: 37101128
[TBL] [Abstract][Full Text] [Related]
28. CircRNA circFOXK2 facilitates oncogenesis in breast cancer via IGF2BP3/miR-370 axis.
Zhang W; Liu H; Jiang J; Yang Y; Wang W; Jia Z
Aging (Albany NY); 2021 Jul; 13(14):18978-18992. PubMed ID: 34329193
[TBL] [Abstract][Full Text] [Related]
29. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway.
Wang B; Chen H; Deng Y; Chen H; Xing L; Guo Y; Wang M; Chen J
J Transl Med; 2023 Mar; 21(1):186. PubMed ID: 36895010
[TBL] [Abstract][Full Text] [Related]
30. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.
Li X; Liang Y; Lian C; Peng F; Xiao Y; He Y; Ma C; Wang Y; Zhang P; Deng Y; Su Y; Luo C; Kong X; Yang Q; Liu T; Hu G
Theranostics; 2021; 11(20):9821-9832. PubMed ID: 34815788
[No Abstract] [Full Text] [Related]
31. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
[TBL] [Abstract][Full Text] [Related]
32. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase.
Zhang L; Cui R; Cheng X; Du J
Cancer Res; 2005 Jan; 65(2):457-64. PubMed ID: 15695387
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
Grotterød I; Maelandsmo GM; Boye K
BMC Cancer; 2010 May; 10():241. PubMed ID: 20507646
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
Marino S; Bishop RT; Mollat P; Idris AI
Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of tumour microenvironment driven by circ-TPGS2/miR-7/TRAF6/NF-κB axis facilitates breast cancer cell motility.
Wang S; Feng X; Wang Y; Li Q; Li X
Autoimmunity; 2021 Aug; 54(5):284-293. PubMed ID: 34036857
[TBL] [Abstract][Full Text] [Related]
37. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
39. Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.
Reuter S; Prasad S; Phromnoi K; Kannappan R; Yadav VR; Aggarwal BB
Mol Cancer Res; 2010 Oct; 8(10):1425-36. PubMed ID: 20826545
[TBL] [Abstract][Full Text] [Related]
40. EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression.
Ju C; Zhou M; Du D; Wang C; Yao J; Li H; Luo Y; He F; He J
Cell Death Dis; 2023 Aug; 14(8):559. PubMed ID: 37626035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
